Skip to content

A multicenter randomized controlled trial of mango needle penetration of the directing vein and Hua Tuo's pinch point as the main treatment for post-stroke motor dysfunction

A multicenter randomized controlled trial of mango needle penetration of the directing vein and Hua Tuo's pinch point as the main treatment for post-stroke motor dysfunction

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078831
Enrollment
Unknown
Registered
2023-12-19
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Mansard group:Using awn needles to penetrate the Vertical Chakra and Hua Tuo Jiao Chi point
Conventional acupuncture group:Treatment with conventional acupuncture
robotics team:Training with robots
core group:Core Muscle Training

Sponsors

The First Affiliated Hospital of Bengbu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for cerebrovascular disease in Western medicine; (2) Meeting the diagnostic criteria for stroke in Chinese medicine; (3) Less than two strokes with a duration of 14-150 days; (4) Age 40-75 years old, regardless of gender; (5) A score of less than 30 on the Berg Balance Scale; (6) The patient's consciousness is clear and his/her condition is stable; (7) The patient is willing to be treated with this method and signs an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Transient ischemic attacks, reversible neurological deficits, etc; (2) Neurological deficits caused by brain tumors, traumatic brain injury, cerebral parasitosis, heart disease, metabolic disorders, and other diseases; (3) Pregnant or lactating women; (4) Patients with severe primary diseases and mental illnesses that are combined with other organs, hematopoietic and endocrine systems; (5) People with comprehension disorders;

Design outcomes

Primary

MeasureTime frame
Surface Electromyography,sEMG;

Secondary

MeasureTime frame
Berg Balance Scale,BBS;Activity of Daily Life ,ADL;Trunk Control Test,TCT;Fugl-Meyer,FMA;Brain derived neurotrophic factor,BDNF;vascular endothelial growth factor,VEGF;

Countries

China

Contacts

Public ContactXu Lei

The First Affiliated Hospital of Bengbu Medical College, Longzihu District, Bengbu City, Anhui Province, China

xuleibyfy@163.com+86 159 5527 8008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026